VERRICA PHARMA Cash Flow - Quarterly (NASDAQ:VRCA)

Add to My Stocks
$17.2 $0.74 (4.5%) VRCA stock closing price Sep 19, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q22018 Q1
Net Income Cash Flow
-7.83M-1.87M
Depreciation Depletion Amortization Cash-Flow--
Net Increase (Decrease) in Assets Liabilities--0.44M
Cash From (used in) Discontinued Operations--
Other Adjustments Net1.58M-
Net Cash from (used by) Operating Activities
-5.83M-2.15M
Increase (Decrease) in Prop Plant And Equipment-0.11M-0.02M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities--
Net Cash from (used by) Investment Activities
-0.11M-0.02M
Issuance (Purchase) of Equity Shares107.25M21M
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities-6.82M-0.01M
Net Cash from (used by) Financing Activities
100.43M20.99M
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
94.49M18.82M
Cash & Equivalents at Beginning of Year8.66M8.66M
Cash & Equivalents at Year End103.15M27.49M
All figures in USD. M: Millions of USD, B: Billions of USD.

Key Financial Ratios For VERRICA PHARMA Cash Flow

Quarterly Cash Flow Statements For VERRICA PHARMA Peers

Akebia Therapeutics cash flow, BioSpecifics Technologies cash flow, Dermira cash flow